2022 | Health Technology Assessment Division

Evidence brief for 24 to 31 December 2022

Posted on February 13, 2023

Evidence brief for 17 to 23 December 2022

Posted on December 28, 2022

For the period of 17 to 23 December 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: https://bit.ly/17 December- 23 December 2022 Document Preview:

[Advisory] Extension of the Call for Nominations to the Health Technology Assessment Council (HTAC) Core Committee and Subcommittee Members until 27 January 2023

Posted on December 22, 2022

Evidence brief for 10 to 16 December 2022

Posted on December 21, 2022

For the period of 10 to 16 December 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 10 – 16 December 2022 Document Preview:

[Department Circular No. 2022 – 0625] Health Technology Assessment Council (HTAC) Recommendation for the Inclusion of Abiraterone Acetate and Non-Inclusion of Enzalutamide for Individuals with Metastatic Castration-Resistant Prostate Cancer in the Philippine National Formulary (PNF)

Posted on December 15, 2022